Sofosbuvir is one of a number of new direct-acting antiviral drugs revolutionising the care of people living with hepatitis C. Combinations of two or three hepatitis C virus direct-acting antiviral drugs taken for 8-24 weeks ...
Aug 4, 2016
0
3
A Hawaiian Airlines flight attendant was among the people in Hawaii infected with Hepatitis A.
Aug 3, 2016
0
3
(HealthDay)—Sharing straws to snort opioids is a major cause of hepatitis C infection, a new study finds.
Jul 28, 2016
0
29
Researchers at Osaka University, Japan uncovered the mechanisms that suppress the propagation of the hepatitis C virus (HCV) with the potential of improving pathological liver conditions. Using model mice, they confirmed ...
Jul 27, 2016
0
2
Research into Africa's first 'screen-and-treat' programme for hepatitis B suggests the initiative may reduce deadly complications of the virus.
Jul 27, 2016
0
2
Prisoners are likely to be the primary risk group for HIV infections in Eastern Europe in the next 15 years, researchers from the University of Bristol have found.
Jul 27, 2016
0
3
Baby boomers, adults born between 1945 and 1965, are five times more likely to have been exposed to the hepatitis C virus (HCV).
Jul 26, 2016
0
6
In mass media and popular culture, medical research is often framed as a race to overcome a complex, seemingly insurmountable challenge, with lives hanging in the balance.
Jul 26, 2016
0
5
Federal health officials on Tuesday approved the first pill to treat all major forms of hepatitis C, the latest in a series of drug approvals that have reshaped treatment of the liver-destroying virus.
Jun 28, 2016
0
15
Virologists from KU Leuven, Belgium, have shown that an experimental antiviral drug against hepatitis C slows down the development of Zika in mice. The research team was led by Professor Johan Neyts from the Laboratory of ...
May 17, 2016
0
1
